United States · FDA National Drug Code directory

CYCLOPHOSPHAMIDE

Source ingredient · 82 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 10019-935_9b5bfec0-7b18-4839-b731-53867588ad53

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-936_9b5bfec0-7b18-4839-b731-53867588ad53

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-937_9b5bfec0-7b18-4839-b731-53867588ad53

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-938_e478e54f-228b-46a1-9347-df729becf777

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-939_e478e54f-228b-46a1-9347-df729becf777

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-942_e478e54f-228b-46a1-9347-df729becf777

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-943_3d950615-927d-441e-b3be-0cebda594df5

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-944_3d950615-927d-441e-b3be-0cebda594df5

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-945_3d950615-927d-441e-b3be-0cebda594df5

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 39822-0250_29b88d00-eeea-7282-e063-6294a90a4024

CYCLOPHOSPHAMIDE

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / XGen Pharmaceuticals DJB, Inc.

United States · Source reference 39822-0255_29b88d00-eeea-7282-e063-6294a90a4024

CYCLOPHOSPHAMIDE

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / XGen Pharmaceuticals DJB, Inc.

United States · Source reference 39822-0260_29b88d00-eeea-7282-e063-6294a90a4024

CYCLOPHOSPHAMIDE

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / XGen Pharmaceuticals DJB, Inc.

United States · Source reference 83703-549_450da59c-b50e-4de0-e063-6394a90a0559

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Bamboo US Bidco LCC

United States · Source reference 83703-550_450da59c-b50e-4de0-e063-6394a90a0559

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Bamboo US Bidco LCC

United States · Source reference 83703-551_450da59c-b50e-4de0-e063-6394a90a0559

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Bamboo US Bidco LCC

United States · Source reference 0054-0382_35c0ebb6-6127-4e3a-9846-4ad17f7d5cd4

Cyclophosphamide

CAPSULE / Hikma Pharmaceuticals USA Inc.

United States · Source reference 0054-0383_35c0ebb6-6127-4e3a-9846-4ad17f7d5cd4

Cyclophosphamide

CAPSULE / Hikma Pharmaceuticals USA Inc.

United States · Source reference 0338-9777_5c81399c-bacb-48ec-8985-836412a07a6d

Cyclophosphamide

INJECTION / Baxter Healthcare Company

United States · Source reference 0338-9779_5c81399c-bacb-48ec-8985-836412a07a6d

Cyclophosphamide

INJECTION / Baxter Healthcare Company

United States · Source reference 0781-3233_2f9d08d0-1f6c-0bf3-e063-6394a90a2b6f

Cyclophosphamide

INJECTION, POWDER, FOR SOLUTION / Sandoz Inc.

United States · Source reference 0781-3244_2f9d08d0-1f6c-0bf3-e063-6394a90a2b6f

Cyclophosphamide

INJECTION, POWDER, FOR SOLUTION / Sandoz Inc.

United States · Source reference 0781-3255_2f9d08d0-1f6c-0bf3-e063-6394a90a2b6f

Cyclophosphamide

INJECTION, POWDER, FOR SOLUTION / Sandoz Inc.

United States · Source reference 0781-3528_3a7a4ad7-90ca-4d84-92f1-c61032067deb

Cyclophosphamide

INJECTION, SOLUTION, CONCENTRATE / Sandoz Inc

United States · Source reference 0781-3529_3a7a4ad7-90ca-4d84-92f1-c61032067deb

Cyclophosphamide

INJECTION, SOLUTION, CONCENTRATE / Sandoz Inc

United States · Source reference 0781-3530_3a7a4ad7-90ca-4d84-92f1-c61032067deb

Cyclophosphamide

INJECTION, SOLUTION, CONCENTRATE / Sandoz Inc

United States · Source reference 10019-955_a466e63c-d425-4387-a41f-d1cd8023f694

Cyclophosphamide

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-956_a466e63c-d425-4387-a41f-d1cd8023f694

Cyclophosphamide

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-957_a466e63c-d425-4387-a41f-d1cd8023f694

Cyclophosphamide

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-982_dc40762e-5ccf-402c-a7b1-4c9dee737811

Cyclophosphamide

TABLET / Baxter Healthcare Corporation

United States · Source reference 10019-984_dc40762e-5ccf-402c-a7b1-4c9dee737811

Cyclophosphamide

TABLET / Baxter Healthcare Corporation

Browse ingredients in United States →